254 - Saying No Is the Easy Part of Quality

254 - Saying No Is the Easy Part of Quality

Quality has a reputation for saying no.


Sometimes that’s exactly the right call. Other times, “no” is just the easiest answer.


In this episode, Subhi breaks down four situations where Quality should absolutely stop the train, and a few where it’s worth stepping back and asking what’s really driving the no in the first place.


Subhi covers:


when there is real patient or product risk

when the evidence doesn’t support the decision

when moving forward would clearly violate requirements or SOPs

when schedule or business pressure is pushing a team to close something that isn’t actually closed


He also talks through some weaker reasons Quality says no, including:


personal preference or “this is how we’ve always done it”

uncertainty from lack of technical familiarity

applying more GMP rigor than the stage of development actually requires


If you work in quality, combination products, development, manufacturing, or technical leadership, this is a practical look at how to think about “no” in a more risk-based way.


Timestamps

00:00 Why Quality Says No

00:45 Channel Intro and Setup

02:02 No When Risk Is Real

03:06 No When Evidence Fails

05:02 No When Requirements Break

05:44 No to Schedule Pressure

07:48 Bad No From Preference

08:33 Bad No From Uncertainty

09:20 Overkill and Phase GMPs

10:08 Build Flexible Quality Culture

12:16 Wrap Up and Takeaways


Subhi Saadeh is a consultant, trainer, auditor, and the Founder and Principal of Let’s Combinate. He has spent his career across medical devices and pharmaceuticals, with experience spanning research and development, industrialization, quality systems, and combination products. Through Let’s Combinate, he helps professionals and organizations better understand and navigate the intersection of drugs, devices, quality, and regulatory requirements.


Connect with Subhi Saadeh

LinkedIn: https://www.linkedin.com/in/subhi-saadeh-1169aa21/

Website: http://letscombinate.com/

Book a quick chat: https://calendly.com/letscombinate/quick-chat

Email: subhi@letscombinate.com


Listen / Follow Let’s Combinate

YouTube: https://www.youtube.com/@LetsCombinate

Spotify: https://open.spotify.com/show/71wYadhCrfLsdYTVachpD2

Apple Podcasts: https://podcasts.apple.com/us/podcast/lets-combinate-drugs-devices/id1589285792


#Quality #CombinationProducts #Pharma #MedTech #RiskManagement #GMP #DesignControls #SupplierQuality #QualitySystems #LetsCombinate

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(264)

256 - The New FDA Inspection Playbook: Where to Start with QMSR

256 - The New FDA Inspection Playbook: Where to Start with QMSR

QMSR became effective on February 2, 2026. Alongside that change, FDA retired the Quality System Inspection Technique (QSIT) and began using the inspection process described in Compliance Program 7382...

28 Sep 9min

255 - Audit Interview Techniques: How Good Auditors Get Better Evidence

255 - Audit Interview Techniques: How Good Auditors Get Better Evidence

A huge part of the job is knowing how to interview people, understand how work is actually performed, and corroborate what you hear against records, observations, and other objective evidence.In this ...

21 Sep 11min

253 - FDA Is Making Big Changes to Its Inspection Approach

253 - FDA Is Making Big Changes to Its Inspection Approach

FDA is changing how it organizes and deploys its investigators but it isn’t simply returning to the old generalist model.Eric Pittman spent more than 20 years at FDA, conducted approximately 800+ insp...

7 Sep 45min

252 - Acceptance Sampling Fundamentals: AQL, Attributes vs Variables, and Risk (OC Curves)

252 - Acceptance Sampling Fundamentals: AQL, Attributes vs Variables, and Risk (OC Curves)

Acceptance sampling is one of the most commonly used and commonly misunderstood tools in quality.In this video, I break down the fundamentals of acceptance sampling: what it is, what an AQL actually m...

31 Aug 13min

251 - The Future of Drug Delivery: Orals, Injectables, Sustainability & Device Strategy

251 - The Future of Drug Delivery: Orals, Injectables, Sustainability & Device Strategy

In this episode, Subhi Saadeh sits down with Steven Kaufman, Founder of Combination Product Solutions, Inc. and fractional Chief Commercial Officer at Portal Instruments, to discuss where the drug del...

24 Aug 49min

I'm Changing The Podcast

I'm Changing The Podcast

After 250 straight weeks of publishing Let’s Combinate every Wednesday, I’m making a change.Starting now, new episodes will go live Mondays at 5:00 AM CT.To everyone who watches, listens, shares, or h...

18 Aug 2min

250 - PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?

250 - PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?

PIC/S has issued its first major update to its qualification and validation recommendations in nearly 20 years. PI 006-4 replaces PI 006-3 from 2007 and brings the document much closer to how qualific...

12 Aug 11min

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
rss-mottagningen
angestpodden
allt-du-velat-veta
rss-ronden
kapitalet-en-podd-om-ekonomi
ufo-sverige
det-morka-psyket
svd-nyhetsartiklar
sexet
rss-spraket
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
4health-med-anna-sparre
vetenskap-och-halsa
halsorevolutionen
rss-vetenskapsradion-2
rss-vetenskapsradion
bildningspodden
medicinvetarna